Sol Shin
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery 4
- Cancer Research top 10%
- MicroRNA in disease regulation 2
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery 2
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 10
-
- Immunotherapy and Immune Responses 6
-
- Extracellular vesicles in disease 12
- RNA Interference and Gene Delivery 4
-
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Jae Hyung ParkSeunglee KwonChan Ho KimWooram UmSoyoung SonHyewon KoJueun JeonHwa Seung Han
- Journals
- Biomaterials (3 papers)Journal of Controlled Release (3 papers)Acta Biomaterialia (2 papers)
- Partner nations
- South KoreaUnited StatesSudan
In The Last Decade
Sol Shin
20 papers receiving 887 citations
Peers
Comparison fields: 5 of 87
- Biomaterials 186
- Cancer Research 179
- Pharmaceutical Science 53
- Biomedical Engineering 352
- Immunology 143
Countries citing papers authored by Sol Shin
This map shows the geographic impact of Sol Shin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sol Shin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sol Shin more than expected).
Fields of papers citing papers by Sol Shin
This network shows the impact of papers produced by Sol Shin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sol Shin. The network helps show where Sol Shin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sol Shin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 25 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 48 | |
| 6 | 2023 | 12 | |
| 7 | 2022 | 51 | |
| 8 | 2022 | 11 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 66 | |
| 11 | 2021 | 50 | |
| 12 | 2021 | 57 | |
| 13 | 2020 | 44 | |
| 14 | 2020 | 66 | |
| 15 | 2020 | 62 | |
| 16 | 2018 | 26 | |
| 17 | 2018 | 75 | |
| 18 | 2017 | 57 | |
| 19 | 2017 | 55 | |
| 20 | 2016 | 94 |
About Sol Shin
Sol Shin is a scholar working on Immunology, Pharmaceutical Science and Biomaterials, having authored 21 papers that have together received 892 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (12 papers), Nanoplatforms for cancer theranostics (10 papers), Immunotherapy and Immune Responses (6 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Biomaterials (186 citations), Cancer Research (179 citations) and Pharmaceutical Science (53 citations). Sol Shin has collaborated with scholars based in South Korea, United States and Sudan. Frequent co-authors include Jae Hyung Park, Seunglee Kwon, Chan Ho Kim, Wooram Um, Soyoung Son, Hyewon Ko, Jueun Jeon, Hwa Seung Han, Jeongjin Lee and Ki Young Choi. Their work appears in journals such as Biomaterials, Journal of Controlled Release, Acta Biomaterialia, International Journal of Biological Macromolecules and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.